secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2022-10-07T23:59:59+00:00
Accession:  0001683168-22-006801
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals appoints Chad White as CFO, succeeding Jerry Dvonch effective Nov 18, 2022
--------------------------------------------------------------------------------

- Jerry Dvonch resigns as CFO effective Nov 18, 2022; will assist transition to Boulder, CO office by Dec 31.
- Chad White appointed interim CFO Oct 3 and permanent CFO Nov 18; previously CFO at Slumber Cloud and Outlast Technologies.
- White receives $230,000 annual salary, bonus up to 50% of salary, and options for 5,000 shares vesting over 3 years.
- Company closing Woodstock, GA office; operations to be centralized in Boulder, CO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/snoa_i8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-006801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer